bioAffinity Technologies, Inc. (NASDAQ:BIAFW – Get Free Report) shot up 4.7% during trading on Monday . The stock traded as high as $0.51 and last traded at $0.51. 800 shares changed hands during trading, a decline of 51% from the average session volume of 1,633 shares. The stock had previously closed at $0.48.
bioAffinity Technologies Price Performance
The stock has a 50-day moving average of $0.57 and a two-hundred day moving average of $0.85.
About bioAffinity Technologies
bioAffinity Technologies, Inc, a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat lung cancer and other diseases of the lung at the cellular level.
Read More
- Five stocks we like better than bioAffinity Technologies
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- 2 Stocks to Gain From Trump Universal Tariffs on Critical Imports
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Rigetti Computing, Inc.: Buy, Sell, or Hold for 2025
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- Delta Can Fly to New Highs in 2025; Here’s Why
Receive News & Ratings for bioAffinity Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for bioAffinity Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
